Industries > Pharma > Global Medical Marijuana Market 2017-2027

Global Medical Marijuana Market 2017-2027

Chronic Pain, Arthritis, Migraine, Cancer, National Markets, Patent Analysis, Leading Companies

PUBLISHED: 22 August 2017
PAGES: 120
PRODUCT CODE: PHA0228
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0228 Categories: , Tag:

The global medical marijuana market was valued at $12bn in 2016 and is projected to grow at a CAGR of 18% in the first half of the forecast period. The market is dominated by the Chronic Pain submarket which held 40% share of that market in 2016.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 120-page report you will receive 87 charts – all unavailable elsewhere.

The 120-page report provides clear detailed insight into the global medical marijuana market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Medical Marijuana Market forecasts from 2017-2027

• Revenue forecast for the medical marijuana market by Application:
• Chronic Pain
• Arthritis
• Migraine
• Cancer
• Others

Each submarket is further divided by region: North America, Europe, RoW

• This report provides individual revenue forecasts to 2027 for these regional and national medical marijuana markets:
• North America:
• USA
• Canada

• Europe:
• Belgium
• Croatia
• Finland
• France
• Italy
• Rest of Europe

• RoW:
• Israel
• Australia
• Other Countries

Global Medical Marijuana Market 2017-2027

• This report discusses the leading companies in the global medical marijuana market:
• Cara Therapeutics, Inc.
• Cannabis Sativa, Inc.
• CannaGrow Holdings, Inc.
• Aphios Corporation
• United Cannabis Corporation
• Growblox Sciences, Inc.
• GreenGro Technologies, Inc.
• GW Pharmaceutical, PLC.
• International Consolidated Companies, Inc.
• Lexaria Biosciences Corp.

• This report also listed 84 other companies involved in medical marijuana production, including their reported revenues (when available) and number of employees

• This report provides a patent analysis table for medical marijuana

• This report discusses the drivers, restraints as well as porter’s five forces analysis of the global medical marijuana market

Visiongain’s study is intended for anyone requiring commercial analyses for the global medical marijuana market. You find data, trends and predictions.

Buy our report today Global Medical Marijuana Market 2017-2027: Chronic Pain, Arthritis, Migraine, Cancer, National Markets, Patent Analysis, Leading Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Medical Marijuana Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Medical Marijuana Market 2017-2027


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories

Category